| 图片 | 名称及描述 | |
|---|---|---|
|
β-D-erythro-Hexos-2-ulo-2,5-furanose, 2,3-dideoxy-2-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-4,6-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-, 1-(methyl hemiacetal), (R)- (9CI)
97%
|
||
|
β-D-erythro-Pentofuranuronamide, N-[4-(chloroacetyl)phenyl]-1,2-dideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)- (9CI)
97%
|
||
|
β-D-erythro-Pentodialdo-1,4-furanose, 1,2-dideoxy-1-[3,4-dihydro-5-methyl-2,4-dioxo-3-(phenylmethyl)-1(2H)-pyrimidinyl]-3-O-(phenylmethyl)- (9CI)
97%
|
||
|
β-D-erythro-Pentofuranuronamide, 1,2-dideoxy-1-(5-fluoro-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-, 3-acetate (9CI, ACI)
97%
|
||
|
β-D-erythro-Heptofuranuronic acid, 1-(5-amino-6,7-dihydro-2,7-dioxothiazolo[4,5-d]pyrimidin-3(2H)-yl)-1,3,5,6-tetradeoxy-5-ethyl-, (5ξ)- (ACI)
97%
|
||
|
β-D-erythro-Pentofuranuronic acid, 1-(2-amino-6-ethoxy-9H-purin-9-yl)-1,2-dideoxy-2-fluoro-4-C-fluoro-2-methyl-, 1,1-dimethylethyl ester, (2R)- (ACI)
97%
|
||
|
β-D-erythro-Pentofuranos-3-ulose, 1-[5-amino-4-(aminocarbonyl)-1H-imidazol-1-yl]-1-deoxy-, cyclic 3-(1,2-ethanediyl acetal) (ACI)
97%
|
||
|
β-D-erythro-Pentofuranos-2-ulose, 1-[5-amino-4-(aminocarbonyl)-1H-imidazol-1-yl]-1-deoxy-, cyclic 2-(1,2-ethanediyl acetal) (ACI)
97%
|
||
|
β-D-erythro-Pentodialdo-1,4-furanose, 1-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,2-dideoxy-2,2-difluoro-, cyclic 5-(1,2-ethanediyl acetal) (ACI)
97%
|
||
|
β-D-erythro-Pentodialdo-1,4-furanose, 1-(6-amino-2-chloro-9H-purin-9-yl)-1,2-dideoxy-, cyclic 5-(1,2-ethanediyl acetal) (ACI)
97%
|
||
|
β-D-erythro-Hex-5-enofuranothymidine, [P(R)]-P-[5-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)pentyl]-5′-O-[(1,1-dimethylethyl)dimethylsilyl]thymidylyl-(3′→6′)-5′,6′-dideoxy-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite], (5′E)- (ACI)
97%
|
||
|
β-D-erythro-Pentofuranuronamide, C-3-amino-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-C-1,2,3-trideoxy-1-thymin-1-yl-β-D-erythro-pentofuranuronoylimino-(5→3)-1,2,3-trideoxy-1-thymin-1-yl-, thymin-1-yl = 3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl (ACI)
97%
|
||
|
β-D-erythro-Hexofuranurononitrile, 1-[5-[(1E)-2-bromoethenyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl]-1,2,5-trideoxy-, 3-acetate (ACI)
97%
|
||
|
β-D-erythro-Hexofuranurononitrile, 1,2,5-trideoxy-1-(5-ethyl-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-, 3-acetate (ACI)
97%
|
||
|
β-D-erythro-Heptofuranothymidine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-P-(2-cyanoethyl)-5-methyl-2′-O,4′-C-methyleneuridylyl-(3′→5′)-6′-deoxy-3′-O-[(1,1-dimethylethyl)diphenylsilyl]-, 7′-(4-methylbenzenesulfonate), (5′ξ)- (ACI)
97%
|
||
|
β-D-erythro-Hexofuranoguanosine, 3′-O-dephosphinicothymidylyl(methylimino)-(3′→6′)-2′,5′,6′-trideoxy-3′-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)
97%
|
||
|
β-D-erythro-Hexofuranocytidine, 3′-O-dephosphinicothymidylyl(methylimino)-(3′→6′)-2′,5′,6′-trideoxy-3′-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)
97%
|
||
|
β-D-erythro-Hexofuranoadenosine, 3′-O-dephosphinicothymidylyl(methylimino)-(3′→6′)-2′,5′,6′-trideoxy-3′-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)
97%
|
||
|
β-D-erythro-Hexofuranothymidine, 5′-O-benzoyl-3′-O-dephosphinicothymidylyl(methylimino)-(3′→6′)-5′,6′-dideoxy-3′-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)
97%
|
||
|
β-D-arabino-Uridine, P-(2-cyanoethyl)-5′-O-[(1,1-dimethylethyl)dimethylsilyl]-2′-O-2-propenyluridylyl-(3′→5′)-3′-O-[(1,1-dimethylethyl)dimethylsilyl]-2′-O-2-propenyl- (9CI)
97%
|

